JP7561029B2 - 炎症性皮膚状態を処置するためのミノサイクリン - Google Patents

炎症性皮膚状態を処置するためのミノサイクリン Download PDF

Info

Publication number
JP7561029B2
JP7561029B2 JP2020537525A JP2020537525A JP7561029B2 JP 7561029 B2 JP7561029 B2 JP 7561029B2 JP 2020537525 A JP2020537525 A JP 2020537525A JP 2020537525 A JP2020537525 A JP 2020537525A JP 7561029 B2 JP7561029 B2 JP 7561029B2
Authority
JP
Japan
Prior art keywords
minocycline
doxycycline
composition
rosacea
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020537525A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021509409A5 (https=
JP2021509409A (ja
JPWO2019135166A5 (https=
Inventor
スワティ クルカルニ，
ビジャイ クマール パディ，
シャンバス アリクンジュ，
ラジーブ シン ラグバンシ，
スリニバス ラムチャンドラ シドギディ，
アニルド ガウタム，
Original Assignee
ドクター レディズ ラボラトリーズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65269058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP7561029(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ドクター レディズ ラボラトリーズ リミテッド filed Critical ドクター レディズ ラボラトリーズ リミテッド
Publication of JP2021509409A publication Critical patent/JP2021509409A/ja
Publication of JP2021509409A5 publication Critical patent/JP2021509409A5/ja
Publication of JPWO2019135166A5 publication Critical patent/JPWO2019135166A5/ja
Priority to JP2024079573A priority Critical patent/JP2024098011A/ja
Application granted granted Critical
Publication of JP7561029B2 publication Critical patent/JP7561029B2/ja
Priority to JP2025219443A priority patent/JP2026031656A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020537525A 2018-01-07 2019-01-07 炎症性皮膚状態を処置するためのミノサイクリン Active JP7561029B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024079573A JP2024098011A (ja) 2018-01-07 2024-05-15 炎症性皮膚状態を処置するためのミノサイクリン
JP2025219443A JP2026031656A (ja) 2018-01-07 2025-12-02 炎症性皮膚状態を処置するためのミノサイクリン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024079573A Division JP2024098011A (ja) 2018-01-07 2024-05-15 炎症性皮膚状態を処置するためのミノサイクリン

Publications (4)

Publication Number Publication Date
JP2021509409A JP2021509409A (ja) 2021-03-25
JP2021509409A5 JP2021509409A5 (https=) 2022-01-17
JPWO2019135166A5 JPWO2019135166A5 (https=) 2022-01-17
JP7561029B2 true JP7561029B2 (ja) 2024-10-03

Family

ID=65269058

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020537525A Active JP7561029B2 (ja) 2018-01-07 2019-01-07 炎症性皮膚状態を処置するためのミノサイクリン
JP2024079573A Pending JP2024098011A (ja) 2018-01-07 2024-05-15 炎症性皮膚状態を処置するためのミノサイクリン
JP2025219443A Pending JP2026031656A (ja) 2018-01-07 2025-12-02 炎症性皮膚状態を処置するためのミノサイクリン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024079573A Pending JP2024098011A (ja) 2018-01-07 2024-05-15 炎症性皮膚状態を処置するためのミノサイクリン
JP2025219443A Pending JP2026031656A (ja) 2018-01-07 2025-12-02 炎症性皮膚状態を処置するためのミノサイクリン

Country Status (11)

Country Link
US (4) US11191740B2 (https=)
EP (1) EP3735249A1 (https=)
JP (3) JP7561029B2 (https=)
KR (1) KR102705507B1 (https=)
CN (1) CN111818927A (https=)
AU (2) AU2019205134B9 (https=)
BR (1) BR112020013789A2 (https=)
CA (1) CA3087838A1 (https=)
EA (1) EA202091653A1 (https=)
MX (1) MX2020007222A (https=)
WO (1) WO2019135166A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
CA3106884C (en) * 2018-07-19 2025-04-01 Doosan Bobcat North America, Inc. DISPLAY POSITION FOR CABIN WITH TILTING DOOR
CN120324439A (zh) * 2025-03-05 2025-07-18 福安药业集团宁波天衡制药有限公司 一种稳定的盐酸米诺环素胶囊及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004536046A (ja) 2001-04-05 2004-12-02 コッラジェネックス ファーマシューチカルス インコーポレイテッド ざ瘡の治療方法
JP2005523313A (ja) 2002-04-16 2005-08-04 コッラジェネックス ファーマシューチカルス インコーポレイテッド 目の酒さ及び酒さ性ざ瘡の同時治療方法
JP2008543936A (ja) 2005-06-24 2008-12-04 メディシス・ファーマシューティカル・コーポレーション にきびの治療方法発明の分野

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004536046A (ja) 2001-04-05 2004-12-02 コッラジェネックス ファーマシューチカルス インコーポレイテッド ざ瘡の治療方法
JP2005523313A (ja) 2002-04-16 2005-08-04 コッラジェネックス ファーマシューチカルス インコーポレイテッド 目の酒さ及び酒さ性ざ瘡の同時治療方法
JP2008543936A (ja) 2005-06-24 2008-12-04 メディシス・ファーマシューティカル・コーポレーション にきびの治療方法発明の分野

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Modern Physician，2014年，Vol.34, No.5，p.619

Also Published As

Publication number Publication date
EA202091653A1 (ru) 2020-12-23
CA3087838A1 (en) 2019-07-11
KR102705507B1 (ko) 2024-09-10
WO2019135166A9 (en) 2020-07-16
AU2019205134A1 (en) 2020-08-20
US10905664B2 (en) 2021-02-02
AU2019205134B2 (en) 2024-11-07
RU2020125984A3 (https=) 2022-02-07
US12594252B2 (en) 2026-04-07
KR20200108018A (ko) 2020-09-16
BR112020013789A2 (pt) 2021-02-17
JP2026031656A (ja) 2026-02-24
JP2021509409A (ja) 2021-03-25
US20200222345A1 (en) 2020-07-16
RU2020125984A (ru) 2022-02-07
AU2019205134A2 (en) 2020-08-20
EP3735249A1 (en) 2020-11-11
US11191740B2 (en) 2021-12-07
AU2019205134B9 (en) 2025-02-20
JP2024098011A (ja) 2024-07-19
US20190209500A1 (en) 2019-07-11
WO2019135166A1 (en) 2019-07-11
CN111818927A (zh) 2020-10-23
US20210121420A1 (en) 2021-04-29
MX2020007222A (es) 2020-12-10
US11364212B2 (en) 2022-06-21
AU2025200826A1 (en) 2025-02-27
US20230131030A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
JP5642691B2 (ja) ジアセレインを含有する医薬組成物
JP2024098011A (ja) 炎症性皮膚状態を処置するためのミノサイクリン
US8067033B2 (en) Stable compositions of famotidine and ibuprofen
KR20210147082A (ko) 디메틸푸마레이트를 포함하는 일일 저용량 투여용 약제학적 조성물
EA037375B1 (ru) Составы с замедленным высвобождением, содержащие колхицин, и способы их применения
JP7592001B2 (ja) エフロルニチンとスリンダクの固定用量複合製剤
CN114209667A (zh) 包含丙戊酸的延迟释放药物制剂和其用途
RU2787528C2 (ru) Миноциклин для лечения воспалительных заболеваний кожи
KR20200116867A (ko) 에스오메프라졸 또는 이의 약학적으로 허용 가능한 염을 포함하고 이중방출 프로파일을 갖는 약학적 조성물
US10300081B2 (en) Modified release doxycycline composition
EA045615B1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
HK40039196A (en) Minocycline for treating inflammatory skin conditions
KR20130094117A (ko) 록소프로펜 방출제어형 제제 및 이의 제조방법
TW201726124A (zh) 二氟甲基鳥氨酸及舒林酸（ｓｕｌｉｎｄａｃ），固定劑量組合調配物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221026

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221026

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230515

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230814

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231115

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240515

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240628

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240920

R150 Certificate of patent or registration of utility model

Ref document number: 7561029

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350